Literature DB >> 19681796

Overload-induced skeletal muscle extracellular matrix remodelling and myofibre growth in mice lacking IL-6.

J P White1, J M Reecy, T A Washington, S Sato, M E Le, J M Davis, L B Wilson, J A Carson.   

Abstract

AIM: Overloading healthy skeletal muscle produces myofibre hypertrophy and extracellular matrix remodelling, and these processes are thought to be interdependent for producing muscle growth. Inflammatory cytokine interleukin-6 (IL-6) gene expression is induced in overloaded skeletal muscle, and the loss of this IL-6 induction can attenuate the hypertrophic response to overload (OV). Although the OV induction of IL-6 in skeletal muscle may be an important regulator of inflammatory processes and satellite cell proliferation, less is known about its role in the regulation of extracellular matrix remodelling. The purpose of the current study was to examine if OV-induced extracellular matrix remodelling, muscle growth, and associated gene expression were altered in mice that lack IL-6, when compared with wild-type mice.
METHODS: Male C57/BL6 (WT) and C57/BL6 x IL-6(-/-) (IL-6(-/-)) mice (10 weeks of age) were assigned to either a sham control or synergist ablation OV treatments for 3, 21 or 56 days. RESULT: Plantaris muscle mass increased 59% in WT and 116% in IL-6(-/-) mice after 21 day OV. Myofibre CSA was also increased by 21 day OV in both WT and IL-6(-/-) mice. OV induced a twofold greater increase in the volume of non-contractile tissue in IL-6(-/-) muscle compared to WT. OV also induced a significantly greater accumulation of hydroxyproline and procollagen-1 mRNA in IL-6(-/-) muscle, when compared with WT muscle after 21 day OV. Transforming growth factor-beta and insulin-like growth factor-1 mRNA expression were also induced to a greater extent in IL-6(-/-) muscle when compared with WT muscle after 21 day OV. There was no effect of IL-6 loss on the induction of myogenin, and cyclin D1 mRNA expression after 3 day OV. However, MyoD mRNA expression in 3 day OV IL-6(-/-) muscle was attenuated when compared with WT OV mice.
CONCLUSION: IL-6 appears to be necessary for the normal regulation of extracellular matrix remodelling during OV-induced growth.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19681796      PMCID: PMC3044433          DOI: 10.1111/j.1748-1716.2009.02029.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  51 in total

1.  Differential gene expression in the rat soleus muscle during early work overload-induced hypertrophy.

Authors:  James A Carson; Dan Nettleton; James M Reecy
Journal:  FASEB J       Date:  2001-12-14       Impact factor: 5.191

2.  Interleukin-6-deficient mice develop mature-onset obesity.

Authors:  Ville Wallenius; Kristina Wallenius; Bo Ahrén; Mats Rudling; Hans Carlsten; Suzanne L Dickson; Claes Ohlsson; John-Olov Jansson
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

3.  Gene expression of receptors for IL-6, LIF, and CNTF in regenerating skeletal muscles.

Authors:  K Kami; Y Morikawa; M Sekimoto; E Senba
Journal:  J Histochem Cytochem       Date:  2000-09       Impact factor: 2.479

4.  Insight into skeletal muscle mechanotransduction: MAPK activation is quantitatively related to tension.

Authors:  L C Martineau; P F Gardiner
Journal:  J Appl Physiol (1985)       Date:  2001-08

5.  Time course of changes in markers of myogenesis in overloaded rat skeletal muscles.

Authors:  G R Adams; F Haddad; K M Baldwin
Journal:  J Appl Physiol (1985)       Date:  1999-11

6.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.

Authors:  P A Kern; S Ranganathan; C Li; L Wood; G Ranganathan
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-05       Impact factor: 4.310

7.  Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise.

Authors:  P W Bodell; E Kodesh; F Haddad; F P Zaldivar; D M Cooper; G R Adams
Journal:  J Appl Physiol (1985)       Date:  2008-12-04

8.  Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy.

Authors:  Antonio L Serrano; Bernat Baeza-Raja; Eusebio Perdiguero; Mercè Jardí; Pura Muñoz-Cánoves
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

9.  Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouse.

Authors:  Kristen A Baltgalvis; Franklin G Berger; Maria Marjorette O Peña; J Mark Davis; James P White; James A Carson
Journal:  Pflugers Arch       Date:  2008-08-19       Impact factor: 3.657

10.  Interleukin-6 and cachexia in ApcMin/+ mice.

Authors:  Kristen A Baltgalvis; Franklin G Berger; Maria Marjorette O Pena; J Mark Davis; Stephanie J Muga; James A Carson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-12-05       Impact factor: 3.619

View more
  21 in total

1.  Muscle excursion does not correlate with increased serial sarcomere number after muscle adaptation to stretched tendon transfer.

Authors:  Mitsuhiko Takahashi; Samuel R Ward; Jan Fridén; Richard L Lieber
Journal:  J Orthop Res       Date:  2012-04-24       Impact factor: 3.494

2.  Changes in muscle fiber contractility and extracellular matrix production during skeletal muscle hypertrophy.

Authors:  Christopher L Mendias; Andrew J Schwartz; Jeremy A Grekin; Jonathan P Gumucio; Kristoffer B Sugg
Journal:  J Appl Physiol (1985)       Date:  2016-12-15

3.  Six1 and Six1 cofactor expression is altered during early skeletal muscle overload in mice.

Authors:  Bradley S Gordon; Diana C Delgado Díaz; James P White; James A Carson; Matthew C Kostek
Journal:  J Physiol Sci       Date:  2012-06-15       Impact factor: 2.781

4.  G protein-coupled receptor 56 regulates mechanical overload-induced muscle hypertrophy.

Authors:  James P White; Christiane D Wrann; Rajesh R Rao; Sreekumaran K Nair; Mark P Jedrychowski; Jae-Sung You; Vicente Martínez-Redondo; Steven P Gygi; Jorge L Ruas; Troy A Hornberger; Zhidan Wu; David J Glass; Xianhua Piao; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-21       Impact factor: 11.205

5.  Skeletal muscle mass recovery from atrophy in IL-6 knockout mice.

Authors:  T A Washington; J P White; J M Davis; L B Wilson; L L Lowe; S Sato; J A Carson
Journal:  Acta Physiol (Oxf)       Date:  2011-04-27       Impact factor: 6.311

6.  Overload-mediated skeletal muscle hypertrophy is not impaired by loss of myofiber STAT3.

Authors:  Joaquín Pérez-Schindler; Mary C Esparza; James McKendry; Leigh Breen; Andrew Philp; Simon Schenk
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-28       Impact factor: 4.249

Review 7.  Skeletal muscle stem cells from animals I. Basic cell biology.

Authors:  Michael V Dodson; Gary J Hausman; Leluo Guan; Min Du; Theodore P Rasmussen; Sylvia P Poulos; Priya Mir; Werner G Bergen; Melinda E Fernyhough; Douglas C McFarland; Robert P Rhoads; Beatrice Soret; James M Reecy; Sandra G Velleman; Zhihua Jiang
Journal:  Int J Biol Sci       Date:  2010-08-31       Impact factor: 6.580

8.  Role of gp130 in basal and exercise-trained skeletal muscle mitochondrial quality control.

Authors:  Dennis K Fix; Justin P Hardee; Song Gao; Brandon N VanderVeen; Kandy T Velázquez; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2018-02-01

9.  IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse.

Authors:  James P White; Melissa J Puppa; Shuichi Sato; Song Gao; Robert L Price; John W Baynes; Matthew C Kostek; Lydia E Matesic; James A Carson
Journal:  Skelet Muscle       Date:  2012-07-06       Impact factor: 4.912

10.  IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse.

Authors:  Matthew C Kostek; Kanneboyina Nagaraju; Emidio Pistilli; Arpana Sali; San-Huei Lai; Brad Gordon; Yi-Wen Chen
Journal:  BMC Musculoskelet Disord       Date:  2012-06-20       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.